Montalescot, Lucile http://orcid.org/0000-0001-8004-4481
Dorard, Géraldine
Speyer, Elodie
Legrand, Karine
Ayav, Carole
Combe, Christian
Stengel, Bénédicte
Untas, Aurélie
Funding for this research was provided by:
Agence Nationale de la Recherche
Amgen Foundation
Fresenius Biotech
GlaxoSmithKline
Lilly Deutschland
Otsuka Pharmaceutical
Baxter International
Merck Sharp and Dohme
Sanofi Genzyme
Vifor Pharma
AstraZeneca Schweiz
Fondation de France
France Rein
Article History
Received: 7 February 2022
Accepted: 29 April 2022
First Online: 13 June 2022
Declarations
:
: CKD-REIN is supported by a public–private partnership with funding from 9 pharmaceutical companies as listed above. This paper has not been published previously in whole or part.
: All legal authorizations were obtained including those from the Comité consultatif sur le traitement de l'information en matière de recherche dans le domaine de la santé (CCTIRS N°12.360), the Commission nationale de l’informatique et des libertés (CNIL N°DR-2012-469), and from the Kremlin-Bicêtre Comité de protection des personnes (CPP N°IDRCB 2012-A00902-41).